Literature DB >> 17439914

Subtle upper limb impairment in asymptomatic multiple sclerosis subjects.

C Solaro1, G Brichetto, M Casadio, L Roccatagliata, P Ruggiu, G L Mancardi, P G Morasso, P Tanganelli, V Sanguineti.   

Abstract

We evaluated upper limb function in multiple sclerosis (MS) subjects (11 clinically definite MS patients and seven clinically isolated syndrome (CIS) subjects), with a normal upper limb standard neurological examination. Subjects performed center-out reaching movements under visual control, with and without vision of the hand. Their movements were recorded through a digitizing tablet. Motor performance was also related to lesion load, estimated from magnetic resonance imaging (MRI). We found that in MS and CIS subjects, under the hand vision condition, movements were significantly less smooth, and had a less symmetric speed profile. However, the observed impairment did not correlate with MRI findings. This result may be interpreted as evidence of a compensatory strategy, elicited by subtle alterations in sensorimotor control.

Entities:  

Mesh:

Year:  2007        PMID: 17439914     DOI: 10.1177/1352458506069926

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

1.  Imagined actions in multiple sclerosis patients: evidence of decline in motor cognitive prediction.

Authors:  Andrea Tacchino; Marco Bove; Ludovico Pedullà; Mario Alberto Battaglia; Charalambos Papaxanthis; Giampaolo Brichetto
Journal:  Exp Brain Res       Date:  2013-06-28       Impact factor: 1.972

2.  Testing the concurrent validity of a naturalistic upper extremity reaching task.

Authors:  S Y Schaefer; C R Hengge
Journal:  Exp Brain Res       Date:  2015-10-05       Impact factor: 1.972

3.  Movement strategies for maintaining standing balance during arm tracking in people with multiple sclerosis.

Authors:  Matthew C Chua; Allison S Hyngstrom; Alexander V Ng; Brian D Schmit
Journal:  J Neurophysiol       Date:  2014-06-25       Impact factor: 2.714

4.  Italian validation of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).

Authors:  Andrea Tacchino; Michela Ponzio; Ludovico Pedullà; Jessica Podda; Margherita Monti Bragadin; Elisabetta Pedrazzoli; Giovanna Konrad; Mario Alberto Battaglia; Lidwine Mokkink; Giampaolo Brichetto
Journal:  Neurol Sci       Date:  2020-05-12       Impact factor: 3.307

5.  The kinematics of handwriting movements as expression of cognitive and sensorimotor impairments in people with multiple sclerosis.

Authors:  Ambra Bisio; Ludovico Pedullà; Laura Bonzano; Andrea Tacchino; Giampaolo Brichetto; Marco Bove
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

6.  A Comparison of Implicit and Explicit Motor Sequence Learning in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Maliheh Sarabandi
Journal:  Sports (Basel)       Date:  2017-06-07

7.  Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test.

Authors:  Ilaria Carpinella; Davide Cattaneo; Maurizio Ferrarin
Journal:  J Neuroeng Rehabil       Date:  2014-04-18       Impact factor: 4.262

8.  Evaluating upper limb impairments in multiple sclerosis by exposure to different mechanical environments.

Authors:  Laura Pellegrino; Martina Coscia; Margit Muller; Claudio Solaro; Maura Casadio
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

9.  Motor Imagery as a Function of Disease Severity in Multiple Sclerosis: An fMRI Study.

Authors:  Andrea Tacchino; Catarina Saiote; Giampaolo Brichetto; Giulia Bommarito; Luca Roccatagliata; Christian Cordano; Mario A Battaglia; Gian L Mancardi; Matilde Inglese
Journal:  Front Hum Neurosci       Date:  2018-01-11       Impact factor: 3.169

10.  Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment.

Authors:  Darrin O Wijeyaratnam; Thomas Edwards; Lara A Pilutti; Erin K Cressman
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.